Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AR042540-02
Application #
2006352
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1995-09-30
Project End
1999-08-31
Budget Start
1996-09-01
Budget End
1997-08-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Hospital for Joint Diseases Ortho Institute
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10003
Sheng, Dan; Kim, Mimi Y (2006) The effects of non-compliance on intent-to-treat analysis of equivalence trials. Stat Med 25:1183-99
Buyon, Jill P; Petri, Michelle A; Kim, Mimi Y et al. (2005) The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 142:953-62
Petri, Michelle; Kim, Mimi Y; Kalunian, Kenneth C et al. (2005) Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353:2550-8
Kim, Mimi Y; Xue, Xiaonan (2004) Likelihood ratio and a Bayesian approach were superior to standard noninferiority analysis when the noninferiority margin varied with the control event rate. J Clin Epidemiol 57:1253-61
Askanase, Anca D (2004) Estrogen therapy in systemic lupus erythematosus. Treat Endocrinol 3:19-26
Kim, Mimi Y; Xue, Xiaonan (2002) The analysis of multivariate interval-censored survival data. Stat Med 21:3715-26
Kim, M Y; Goldberg, J D (2001) The effects of outcome misclassification and measurement error on the design and analysis of therapeutic equivalence trials. Stat Med 20:2065-78
Buyon, J P; Kalunian, K C; Ramsey-Goldman, R et al. (1999) Assessing disease activity in SLE patients during pregnancy. Lupus 8:677-84
Kim, M Y; Buyon, J P; Petri, M et al. (1999) Equivalence trials in SLE research: issues to consider. Lupus 8:620-6
Petri, M; Buyon, J; Kim, M (1999) Classification and definition of major flares in SLE clinical trials. Lupus 8:685-91

Showing the most recent 10 out of 11 publications